Drug-Refractory Dystonia: Benefits of Lamotrigine Therapy in a Case of SCN2A Epilepsy-Dyskinesia Syndrome.

IF 3.4 4区医学 Q2 CLINICAL NEUROLOGY

Movement Disorders Clinical Practice Pub Date : 2026-10-08 DOI:10.1002/mdc3.70842

Isobel S Platt, Patrick B Moloney, Sanjay M Sisodiya, Thomas T Warner

引用次数: 0

查看原文本刊更多论文

药物难治性肌张力障碍：拉莫三嗪治疗一例SCN2A癫痫-运动障碍综合征的益处

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Movement Disorders Clinical Practice CLINICAL NEUROLOGY-

CiteScore

4.00

自引率

7.50%

发文量

218

期刊介绍： Movement Disorders Clinical Practice- is an online-only journal committed to publishing high quality peer reviewed articles related to clinical aspects of movement disorders which broadly include phenomenology (interesting case/case series/rarities), investigative (for e.g- genetics, imaging), translational (phenotype-genotype or other) and treatment aspects (clinical guidelines, diagnostic and treatment algorithms)